Fact CheckerSign in

NCT06899698Not yet recruiting

INSPIRATORY MUSCLE TRAINER ON AUTONOMIC MODULATION AND PULMONARY FUNCTION

EFFECT OF INSPIRATORY MUSCLE TRAINER ON AUTONOMIC MODULATION AND PULMONARY FUNCTION IN PATIENTS WITH STROKE

Source: ClinicalTrials.gov · Last updated 28 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Stroke individuals with hemiplegia often display difficulties in mobility, cardiopulmonary function...etc. All stroke patients had restrictive pulmonary dysfunction. Therefore, respiratory training improves their respiratory capacity, and orthostatic stress mediated respiratory, cardiovascular and autonomic response. Respiratory muscle training interventions are efficient in terms of pulmonary functional parameters. In advanced line, this study will be conducted to evaluate inspiratory muscle trainer effect on autonomic modulation and pulmonary function in stroke patients.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
20 Mar 2025
Start date
1 Apr 2025
Primary completion date
1 Jun 2025
Lead sponsor
Adly A Adam
Diseases
Stroke
NCT number
NCT06899698

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Apr 2025 to the primary completion date, 1 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous lung surgery.

Other illness

  • Patients with chest infection.
  • Patients with pleural diseases.
  • Primary valvular disease.
  • History of spontaneous pneumothorax.
  • Clinically significant peripheral vascular disease.
  • Severe anemia being unable to follow RMT instructions or complete the questionnaires of the study due to cognitive impairment .
  • Patients with chronic renal failure.

Other

  • Unstable cardiovascular problems.
  • Asthmatic patient.
  • Implanted pacemaker
  • Long-term oxygen treatment.
  • Any patient enrolled in an anther research study for at least 30 days.
  • Facial affection

Who the study is looking for

  • Chronic hemiplegic post stroke patients 'at least 6months'
  • Men.
  • Age ranged 55-65years old.
  • Body mass index ranged from 29.9- 34.9 kg/m2
  • Mini-Mental State Examination (MMSE) scores of 23-27 indicate mild cognitive impairment
  • Did not participate in any selective exercise program for the respiratory muscles before.
  • Participants suffering from orthostatic hypotension a systolic BP decline ≥20 mm Hg or a diastolic BP decline ≥10 mm Hg on position change from sitting to standing.
    • Smokers will be defined as those (who had smoked \>400 cigarettes in their lifetime)

Age in the registry: 55 years to 65 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Physical Therapy Faculty
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.